MedPath

BioRegen Biomedical (Changzhou) Co.,Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

3 Phases

Phase 1:1
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 1
1 (33.3%)
Phase 4
1 (33.3%)

The Efficacy of A New Crosslinked Hyaluronan Gel in Prevention of Intrauterine Adhesion

Not Applicable
Completed
Conditions
Intrauterine Adhesion
First Posted Date
2017-11-27
Last Posted Date
2017-11-27
Lead Sponsor
BioRegen Biomedical (CHangzhou) Co., Ltd
Target Recruit Count
300
Registration Number
NCT03353909

The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions

Phase 1
Completed
Conditions
Myomas
Ovary Cysts
Endometriotic Cysts
Adhesions
First Posted Date
2014-06-18
Last Posted Date
2014-06-18
Lead Sponsor
BioRegen Biomedical (CHangzhou) Co., Ltd
Target Recruit Count
216
Registration Number
NCT02166554
Locations
🇨🇳

Beijing Chao-Yang Hospital, Beijing, Beijing, China

🇨🇳

China-Japan Friendship Hospital, Beijing, Beijing, China

🇨🇳

Peking University First Hospital, Beijing, Beijing, China

and more 4 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath